nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—ABCC1—Dactinomycin—kidney cancer	0.0785	0.121	CbGbCtD
Ofloxacin—SLC22A5—Dactinomycin—kidney cancer	0.0746	0.115	CbGbCtD
Ofloxacin—ABCC1—Paclitaxel—kidney cancer	0.056	0.0865	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—kidney cancer	0.0545	0.0841	CbGbCtD
Ofloxacin—ABCC1—Vinblastine—kidney cancer	0.0492	0.0758	CbGbCtD
Ofloxacin—ABCC1—Vincristine—kidney cancer	0.0483	0.0746	CbGbCtD
Ofloxacin—ABCC2—Paclitaxel—kidney cancer	0.0415	0.064	CbGbCtD
Ofloxacin—ABCC2—Sorafenib—kidney cancer	0.0369	0.0569	CbGbCtD
Ofloxacin—ABCC2—Vinblastine—kidney cancer	0.0364	0.0561	CbGbCtD
Ofloxacin—ABCC2—Vincristine—kidney cancer	0.0358	0.0552	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—kidney cancer	0.0302	0.0466	CbGbCtD
Ofloxacin—ABCC2—Sunitinib—kidney cancer	0.0299	0.0461	CbGbCtD
Ofloxacin—CYP1A2—Pazopanib—kidney cancer	0.0237	0.0365	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—kidney cancer	0.0224	0.0345	CbGbCtD
Ofloxacin—CYP1A2—Erlotinib—kidney cancer	0.0169	0.0261	CbGbCtD
Ofloxacin—CYP1A2—Sorafenib—kidney cancer	0.0137	0.0212	CbGbCtD
Ofloxacin—CYP1A2—urine—kidney cancer	0.0022	0.135	CbGeAlD
Ofloxacin—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00153	0.296	CbGdCrCtD
Ofloxacin—SLC22A6—nephron tubule—kidney cancer	0.00144	0.0889	CbGeAlD
Ofloxacin—SLC22A6—cortex of kidney—kidney cancer	0.00124	0.0761	CbGeAlD
Ofloxacin—SLC22A4—nephron tubule—kidney cancer	0.000987	0.0608	CbGeAlD
Ofloxacin—SLC22A4—renal system—kidney cancer	0.000897	0.0553	CbGeAlD
Ofloxacin—SLC22A4—kidney—kidney cancer	0.000867	0.0534	CbGeAlD
Ofloxacin—SLC22A4—cortex of kidney—kidney cancer	0.000845	0.052	CbGeAlD
Ofloxacin—ABCC2—nephron tubule—kidney cancer	0.000843	0.0519	CbGeAlD
Ofloxacin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.000824	0.16	CbGdCrCtD
Ofloxacin—ABCC2—renal system—kidney cancer	0.000766	0.0472	CbGeAlD
Ofloxacin—ABCC2—kidney—kidney cancer	0.000741	0.0456	CbGeAlD
Ofloxacin—ABCC2—cortex of kidney—kidney cancer	0.000722	0.0444	CbGeAlD
Ofloxacin—SLC22A5—nephron tubule—kidney cancer	0.000653	0.0402	CbGeAlD
Ofloxacin—ABCC1—cortex of kidney—kidney cancer	0.000636	0.0391	CbGeAlD
Ofloxacin—ABCC1—cardiac atrium—kidney cancer	0.000605	0.0372	CbGeAlD
Ofloxacin—SLC22A5—renal system—kidney cancer	0.000594	0.0366	CbGeAlD
Ofloxacin—SLC22A5—kidney—kidney cancer	0.000574	0.0353	CbGeAlD
Ofloxacin—SLC22A5—cortex of kidney—kidney cancer	0.000559	0.0344	CbGeAlD
Ofloxacin—CYP1A2—renal system—kidney cancer	0.000538	0.0331	CbGeAlD
Ofloxacin—SLC22A5—cardiac atrium—kidney cancer	0.000532	0.0327	CbGeAlD
Ofloxacin—TOP2A—Vindesine—Vinblastine—kidney cancer	0.000419	0.0813	CbGdCrCtD
Ofloxacin—TOP2A—Vindesine—Vincristine—kidney cancer	0.000419	0.0813	CbGdCrCtD
Ofloxacin—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.000395	0.0765	CbGdCrCtD
Ofloxacin—Norfloxacin—CYP1A1—kidney cancer	0.00028	0.311	CrCbGaD
Ofloxacin—TOP2A—Vinorelbine—Vincristine—kidney cancer	0.000264	0.0513	CbGdCrCtD
Ofloxacin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	0.000264	0.0513	CbGdCrCtD
Ofloxacin—Sparfloxacin—ABCB1—kidney cancer	0.000261	0.289	CrCbGaD
Ofloxacin—TOP2A—Vincristine—Vinblastine—kidney cancer	0.000226	0.0438	CbGdCrCtD
Ofloxacin—Levofloxacin—ABCB1—kidney cancer	0.000183	0.204	CrCbGaD
Ofloxacin—TOP2A—Vinblastine—Vincristine—kidney cancer	0.000182	0.0353	CbGdCrCtD
Ofloxacin—Ciprofloxacin—ABCB1—kidney cancer	0.000177	0.197	CrCbGaD
Ofloxacin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	0.000149	0.0288	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	0.000127	0.0247	CbGdCrCtD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—kidney cancer	0.000127	0.0247	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—kidney cancer	0.000127	0.0247	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	0.000107	0.0207	CbGdCrCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	9.05e-05	0.00314	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—EGR1—kidney cancer	9.03e-05	0.00313	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	8.84e-05	0.00307	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	8.68e-05	0.00301	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	8.6e-05	0.00298	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.38e-05	0.00291	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	8.38e-05	0.00291	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A3—kidney cancer	8.36e-05	0.0029	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ATP7B—kidney cancer	8.36e-05	0.0029	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ANXA2—kidney cancer	8.36e-05	0.0029	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	8.2e-05	0.00285	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—GSTP1—kidney cancer	8.11e-05	0.00281	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—GSTM1—kidney cancer	7.45e-05	0.00259	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	6.83e-05	0.00237	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	6.8e-05	0.00236	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—kidney cancer	6.68e-05	0.00232	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	6.68e-05	0.00232	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	6.68e-05	0.00232	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—GSTT1—kidney cancer	6.58e-05	0.00229	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	6.58e-05	0.00228	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—ALDH1A1—kidney cancer	6.56e-05	0.00228	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	6.55e-05	0.00227	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	6.37e-05	0.00221	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	6.33e-05	0.0022	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.31e-05	0.00219	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.31e-05	0.00219	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.31e-05	0.00219	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—kidney cancer	6.28e-05	0.00218	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	6.25e-05	0.00217	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.11e-05	0.00212	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.11e-05	0.00212	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.11e-05	0.00212	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	6.05e-05	0.0021	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.04e-05	0.0021	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.04e-05	0.0021	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.04e-05	0.0021	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PSMD7—kidney cancer	5.99e-05	0.00208	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.87e-05	0.00204	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—AURKA—kidney cancer	5.83e-05	0.00202	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—kidney cancer	5.77e-05	0.002	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.67e-05	0.00197	CbGpPWpGaD
Ofloxacin—Dizziness—Sunitinib—kidney cancer	5.45e-05	0.000181	CcSEcCtD
Ofloxacin—Feeling abnormal—Gemcitabine—kidney cancer	5.45e-05	0.000181	CcSEcCtD
Ofloxacin—Shock—Paclitaxel—kidney cancer	5.45e-05	0.000181	CcSEcCtD
Ofloxacin—Vomiting—Sorafenib—kidney cancer	5.44e-05	0.000181	CcSEcCtD
Ofloxacin—Orthostatic hypotension—Doxorubicin—kidney cancer	5.44e-05	0.000181	CcSEcCtD
Ofloxacin—Nervous system disorder—Paclitaxel—kidney cancer	5.43e-05	0.000181	CcSEcCtD
Ofloxacin—Hypokalaemia—Doxorubicin—kidney cancer	5.42e-05	0.00018	CcSEcCtD
Ofloxacin—Thrombocytopenia—Paclitaxel—kidney cancer	5.42e-05	0.00018	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	5.4e-05	0.00188	CbGpPWpGaD
Ofloxacin—Tachycardia—Paclitaxel—kidney cancer	5.4e-05	0.00018	CcSEcCtD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	5.4e-05	0.00187	CbGpPWpGaD
Ofloxacin—Rash—Sorafenib—kidney cancer	5.4e-05	0.00018	CcSEcCtD
Ofloxacin—Dermatitis—Sorafenib—kidney cancer	5.39e-05	0.000179	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ACY1—kidney cancer	5.39e-05	0.00187	CbGpPWpGaD
Ofloxacin—Back pain—Capecitabine—kidney cancer	5.38e-05	0.000179	CcSEcCtD
Ofloxacin—Breast disorder—Doxorubicin—kidney cancer	5.38e-05	0.000179	CcSEcCtD
Ofloxacin—Skin disorder—Paclitaxel—kidney cancer	5.38e-05	0.000179	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	5.36e-05	0.000178	CcSEcCtD
Ofloxacin—Headache—Sorafenib—kidney cancer	5.36e-05	0.000178	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—PSMD7—kidney cancer	5.36e-05	0.00186	CbGpPWpGaD
Ofloxacin—Muscle spasms—Capecitabine—kidney cancer	5.35e-05	0.000178	CcSEcCtD
Ofloxacin—Hyperhidrosis—Paclitaxel—kidney cancer	5.35e-05	0.000178	CcSEcCtD
Ofloxacin—Diarrhoea—Dactinomycin—kidney cancer	5.34e-05	0.000177	CcSEcCtD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	5.33e-05	0.00185	CbGpPWpGaD
Ofloxacin—Nasopharyngitis—Doxorubicin—kidney cancer	5.33e-05	0.000177	CcSEcCtD
Ofloxacin—Anorexia—Paclitaxel—kidney cancer	5.28e-05	0.000175	CcSEcCtD
Ofloxacin—Gastritis—Doxorubicin—kidney cancer	5.27e-05	0.000175	CcSEcCtD
Ofloxacin—Vision blurred—Capecitabine—kidney cancer	5.25e-05	0.000174	CcSEcCtD
Ofloxacin—Vomiting—Sunitinib—kidney cancer	5.24e-05	0.000174	CcSEcCtD
Ofloxacin—Body temperature increased—Gemcitabine—kidney cancer	5.23e-05	0.000174	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—AURKA—kidney cancer	5.21e-05	0.00181	CbGpPWpGaD
Ofloxacin—Tremor—Capecitabine—kidney cancer	5.21e-05	0.000173	CcSEcCtD
Ofloxacin—Rash—Sunitinib—kidney cancer	5.19e-05	0.000173	CcSEcCtD
Ofloxacin—Dermatitis—Sunitinib—kidney cancer	5.19e-05	0.000173	CcSEcCtD
Ofloxacin—Abdominal distension—Doxorubicin—kidney cancer	5.18e-05	0.000172	CcSEcCtD
Ofloxacin—Hypotension—Paclitaxel—kidney cancer	5.17e-05	0.000172	CcSEcCtD
Ofloxacin—Ill-defined disorder—Capecitabine—kidney cancer	5.16e-05	0.000172	CcSEcCtD
Ofloxacin—Headache—Sunitinib—kidney cancer	5.16e-05	0.000172	CcSEcCtD
Ofloxacin—Dysphagia—Doxorubicin—kidney cancer	5.15e-05	0.000171	CcSEcCtD
Ofloxacin—Asthma—Doxorubicin—kidney cancer	5.15e-05	0.000171	CcSEcCtD
Ofloxacin—Anaemia—Capecitabine—kidney cancer	5.14e-05	0.000171	CcSEcCtD
Ofloxacin—ABCC1—Disease—CCBL1—kidney cancer	5.14e-05	0.00178	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Vincristine—kidney cancer	5.13e-05	0.000171	CcSEcCtD
Ofloxacin—Eosinophilia—Doxorubicin—kidney cancer	5.1e-05	0.00017	CcSEcCtD
Ofloxacin—Nausea—Sorafenib—kidney cancer	5.09e-05	0.000169	CcSEcCtD
Ofloxacin—Pancreatitis—Doxorubicin—kidney cancer	5.05e-05	0.000168	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.04e-05	0.000168	CcSEcCtD
Ofloxacin—Malaise—Capecitabine—kidney cancer	5.02e-05	0.000167	CcSEcCtD
Ofloxacin—Angina pectoris—Doxorubicin—kidney cancer	5.02e-05	0.000167	CcSEcCtD
Ofloxacin—Insomnia—Paclitaxel—kidney cancer	5.01e-05	0.000166	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	5e-05	0.00174	CbGpPWpGaD
Ofloxacin—Vertigo—Capecitabine—kidney cancer	5e-05	0.000166	CcSEcCtD
Ofloxacin—Asthenia—Vincristine—kidney cancer	5e-05	0.000166	CcSEcCtD
Ofloxacin—Syncope—Capecitabine—kidney cancer	4.99e-05	0.000166	CcSEcCtD
Ofloxacin—Leukopenia—Capecitabine—kidney cancer	4.98e-05	0.000166	CcSEcCtD
Ofloxacin—Paraesthesia—Paclitaxel—kidney cancer	4.97e-05	0.000165	CcSEcCtD
Ofloxacin—Vomiting—Dactinomycin—kidney cancer	4.96e-05	0.000165	CcSEcCtD
Ofloxacin—Bronchitis—Doxorubicin—kidney cancer	4.95e-05	0.000165	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.95e-05	0.00172	CbGpPWpGaD
Ofloxacin—Dyspnoea—Paclitaxel—kidney cancer	4.93e-05	0.000164	CcSEcCtD
Ofloxacin—Somnolence—Paclitaxel—kidney cancer	4.92e-05	0.000164	CcSEcCtD
Ofloxacin—Palpitations—Capecitabine—kidney cancer	4.92e-05	0.000164	CcSEcCtD
Ofloxacin—Rash—Dactinomycin—kidney cancer	4.92e-05	0.000164	CcSEcCtD
Ofloxacin—Nausea—Sunitinib—kidney cancer	4.89e-05	0.000163	CcSEcCtD
Ofloxacin—Loss of consciousness—Capecitabine—kidney cancer	4.89e-05	0.000163	CcSEcCtD
Ofloxacin—Pancytopenia—Doxorubicin—kidney cancer	4.89e-05	0.000163	CcSEcCtD
Ofloxacin—Dyspepsia—Paclitaxel—kidney cancer	4.87e-05	0.000162	CcSEcCtD
Ofloxacin—Cough—Capecitabine—kidney cancer	4.86e-05	0.000162	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	4.84e-05	0.00168	CbGpPWpGaD
Ofloxacin—Neutropenia—Doxorubicin—kidney cancer	4.81e-05	0.00016	CcSEcCtD
Ofloxacin—Dysuria—Doxorubicin—kidney cancer	4.81e-05	0.00016	CcSEcCtD
Ofloxacin—Decreased appetite—Paclitaxel—kidney cancer	4.81e-05	0.00016	CcSEcCtD
Ofloxacin—Hypertension—Capecitabine—kidney cancer	4.81e-05	0.00016	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Doxorubicin—kidney cancer	4.79e-05	0.000159	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.78e-05	0.000159	CcSEcCtD
Ofloxacin—Fatigue—Paclitaxel—kidney cancer	4.77e-05	0.000159	CcSEcCtD
Ofloxacin—Diarrhoea—Vincristine—kidney cancer	4.77e-05	0.000159	CcSEcCtD
Ofloxacin—Pollakiuria—Doxorubicin—kidney cancer	4.76e-05	0.000158	CcSEcCtD
Ofloxacin—Asthenia—Gemcitabine—kidney cancer	4.74e-05	0.000158	CcSEcCtD
Ofloxacin—Myalgia—Capecitabine—kidney cancer	4.74e-05	0.000158	CcSEcCtD
Ofloxacin—Arthralgia—Capecitabine—kidney cancer	4.74e-05	0.000158	CcSEcCtD
Ofloxacin—Chest pain—Capecitabine—kidney cancer	4.74e-05	0.000158	CcSEcCtD
Ofloxacin—Pain—Paclitaxel—kidney cancer	4.73e-05	0.000157	CcSEcCtD
Ofloxacin—Constipation—Paclitaxel—kidney cancer	4.73e-05	0.000157	CcSEcCtD
Ofloxacin—Anxiety—Capecitabine—kidney cancer	4.72e-05	0.000157	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.71e-05	0.000156	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Doxorubicin—kidney cancer	4.7e-05	0.000156	CcSEcCtD
Ofloxacin—Discomfort—Capecitabine—kidney cancer	4.68e-05	0.000156	CcSEcCtD
Ofloxacin—Pruritus—Gemcitabine—kidney cancer	4.68e-05	0.000156	CcSEcCtD
Ofloxacin—Weight decreased—Doxorubicin—kidney cancer	4.66e-05	0.000155	CcSEcCtD
Ofloxacin—ABCC1—Disease—AMER1—kidney cancer	4.65e-05	0.00161	CbGpPWpGaD
Ofloxacin—Hyperglycaemia—Doxorubicin—kidney cancer	4.64e-05	0.000154	CcSEcCtD
Ofloxacin—Dry mouth—Capecitabine—kidney cancer	4.63e-05	0.000154	CcSEcCtD
Ofloxacin—Nausea—Dactinomycin—kidney cancer	4.63e-05	0.000154	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—kidney cancer	4.63e-05	0.00161	CbGpPWpGaD
Ofloxacin—Pneumonia—Doxorubicin—kidney cancer	4.62e-05	0.000154	CcSEcCtD
Ofloxacin—Dizziness—Vincristine—kidney cancer	4.61e-05	0.000153	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.59e-05	0.00159	CbGpPWpGaD
Ofloxacin—Infestation NOS—Doxorubicin—kidney cancer	4.59e-05	0.000153	CcSEcCtD
Ofloxacin—Infestation—Doxorubicin—kidney cancer	4.59e-05	0.000153	CcSEcCtD
Ofloxacin—Drowsiness—Doxorubicin—kidney cancer	4.59e-05	0.000153	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.58e-05	0.00159	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PDHB—kidney cancer	4.58e-05	0.00159	CbGpPWpGaD
Ofloxacin—Confusional state—Capecitabine—kidney cancer	4.58e-05	0.000152	CcSEcCtD
Ofloxacin—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	4.56e-05	0.00158	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Paclitaxel—kidney cancer	4.56e-05	0.000152	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.55e-05	0.000151	CcSEcCtD
Ofloxacin—Oedema—Capecitabine—kidney cancer	4.54e-05	0.000151	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Paclitaxel—kidney cancer	4.53e-05	0.000151	CcSEcCtD
Ofloxacin—Diarrhoea—Gemcitabine—kidney cancer	4.52e-05	0.00015	CcSEcCtD
Ofloxacin—Renal failure—Doxorubicin—kidney cancer	4.51e-05	0.00015	CcSEcCtD
Ofloxacin—Infection—Capecitabine—kidney cancer	4.51e-05	0.00015	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Doxorubicin—kidney cancer	4.5e-05	0.00015	CcSEcCtD
Ofloxacin—Stomatitis—Doxorubicin—kidney cancer	4.47e-05	0.000149	CcSEcCtD
Ofloxacin—Jaundice—Doxorubicin—kidney cancer	4.47e-05	0.000149	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.47e-05	0.00155	CbGpPWpGaD
Ofloxacin—Shock—Capecitabine—kidney cancer	4.47e-05	0.000149	CcSEcCtD
Ofloxacin—Conjunctivitis—Doxorubicin—kidney cancer	4.46e-05	0.000148	CcSEcCtD
Ofloxacin—Nervous system disorder—Capecitabine—kidney cancer	4.45e-05	0.000148	CcSEcCtD
Ofloxacin—Thrombocytopenia—Capecitabine—kidney cancer	4.45e-05	0.000148	CcSEcCtD
Ofloxacin—Tachycardia—Capecitabine—kidney cancer	4.43e-05	0.000147	CcSEcCtD
Ofloxacin—Vomiting—Vincristine—kidney cancer	4.43e-05	0.000147	CcSEcCtD
Ofloxacin—Skin disorder—Capecitabine—kidney cancer	4.41e-05	0.000147	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.41e-05	0.00153	CbGpPWpGaD
Ofloxacin—Urticaria—Paclitaxel—kidney cancer	4.4e-05	0.000146	CcSEcCtD
Ofloxacin—Rash—Vincristine—kidney cancer	4.39e-05	0.000146	CcSEcCtD
Ofloxacin—Hyperhidrosis—Capecitabine—kidney cancer	4.39e-05	0.000146	CcSEcCtD
Ofloxacin—Dermatitis—Vincristine—kidney cancer	4.39e-05	0.000146	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—kidney cancer	4.38e-05	0.00152	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.38e-05	0.00152	CbGpPWpGaD
Ofloxacin—Haematuria—Doxorubicin—kidney cancer	4.38e-05	0.000146	CcSEcCtD
Ofloxacin—Body temperature increased—Paclitaxel—kidney cancer	4.38e-05	0.000146	CcSEcCtD
Ofloxacin—Abdominal pain—Paclitaxel—kidney cancer	4.38e-05	0.000146	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.37e-05	0.00152	CbGpPWpGaD
Ofloxacin—Headache—Vincristine—kidney cancer	4.37e-05	0.000145	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.36e-05	0.00151	CbGpPWpGaD
Ofloxacin—Hepatobiliary disease—Doxorubicin—kidney cancer	4.34e-05	0.000144	CcSEcCtD
Ofloxacin—Epistaxis—Doxorubicin—kidney cancer	4.33e-05	0.000144	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.33e-05	0.0015	CbGpPWpGaD
Ofloxacin—Anorexia—Capecitabine—kidney cancer	4.33e-05	0.000144	CcSEcCtD
Ofloxacin—Sinusitis—Doxorubicin—kidney cancer	4.31e-05	0.000143	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CCBL1—kidney cancer	4.31e-05	0.00149	CbGpPWpGaD
Ofloxacin—Agranulocytosis—Doxorubicin—kidney cancer	4.28e-05	0.000142	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.26e-05	0.00148	CbGpPWpGaD
Ofloxacin—Hypotension—Capecitabine—kidney cancer	4.24e-05	0.000141	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.22e-05	0.00146	CbGpPWpGaD
Ofloxacin—Vomiting—Gemcitabine—kidney cancer	4.2e-05	0.00014	CcSEcCtD
Ofloxacin—Bradycardia—Doxorubicin—kidney cancer	4.2e-05	0.00014	CcSEcCtD
Ofloxacin—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	4.19e-05	0.00146	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—JUN—kidney cancer	4.19e-05	0.00145	CbGpPWpGaD
Ofloxacin—Rash—Gemcitabine—kidney cancer	4.17e-05	0.000139	CcSEcCtD
Ofloxacin—Dermatitis—Gemcitabine—kidney cancer	4.16e-05	0.000138	CcSEcCtD
Ofloxacin—Haemoglobin—Doxorubicin—kidney cancer	4.14e-05	0.000138	CcSEcCtD
Ofloxacin—Headache—Gemcitabine—kidney cancer	4.14e-05	0.000138	CcSEcCtD
Ofloxacin—Nausea—Vincristine—kidney cancer	4.14e-05	0.000138	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.14e-05	0.000138	CcSEcCtD
Ofloxacin—Rhinitis—Doxorubicin—kidney cancer	4.13e-05	0.000137	CcSEcCtD
Ofloxacin—Haemorrhage—Doxorubicin—kidney cancer	4.12e-05	0.000137	CcSEcCtD
Ofloxacin—Hepatitis—Doxorubicin—kidney cancer	4.12e-05	0.000137	CcSEcCtD
Ofloxacin—Insomnia—Capecitabine—kidney cancer	4.11e-05	0.000137	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	4.11e-05	0.00143	CbGpPWpGaD
Ofloxacin—Hypoaesthesia—Doxorubicin—kidney cancer	4.1e-05	0.000136	CcSEcCtD
Ofloxacin—Pharyngitis—Doxorubicin—kidney cancer	4.09e-05	0.000136	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	4.09e-05	0.00142	CbGpPWpGaD
Ofloxacin—Paraesthesia—Capecitabine—kidney cancer	4.08e-05	0.000136	CcSEcCtD
Ofloxacin—Hypersensitivity—Paclitaxel—kidney cancer	4.08e-05	0.000136	CcSEcCtD
Ofloxacin—Urinary tract disorder—Doxorubicin—kidney cancer	4.07e-05	0.000135	CcSEcCtD
Ofloxacin—Oedema peripheral—Doxorubicin—kidney cancer	4.06e-05	0.000135	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—PTEN—kidney cancer	4.05e-05	0.00141	CbGpPWpGaD
Ofloxacin—Connective tissue disorder—Doxorubicin—kidney cancer	4.05e-05	0.000135	CcSEcCtD
Ofloxacin—Dyspnoea—Capecitabine—kidney cancer	4.05e-05	0.000135	CcSEcCtD
Ofloxacin—Urethral disorder—Doxorubicin—kidney cancer	4.04e-05	0.000134	CcSEcCtD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.03e-05	0.0014	CbGpPWpGaD
Ofloxacin—Dyspepsia—Capecitabine—kidney cancer	4e-05	0.000133	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	3.97e-05	0.00138	CbGpPWpGaD
Ofloxacin—Visual impairment—Doxorubicin—kidney cancer	3.97e-05	0.000132	CcSEcCtD
Ofloxacin—Asthenia—Paclitaxel—kidney cancer	3.97e-05	0.000132	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—BRCA2—kidney cancer	3.95e-05	0.00137	CbGpPWpGaD
Ofloxacin—Decreased appetite—Capecitabine—kidney cancer	3.95e-05	0.000131	CcSEcCtD
Ofloxacin—Nausea—Gemcitabine—kidney cancer	3.93e-05	0.000131	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Capecitabine—kidney cancer	3.92e-05	0.00013	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—CDKN2B—kidney cancer	3.92e-05	0.00136	CbGpPWpGaD
Ofloxacin—Fatigue—Capecitabine—kidney cancer	3.92e-05	0.00013	CcSEcCtD
Ofloxacin—Pruritus—Paclitaxel—kidney cancer	3.92e-05	0.00013	CcSEcCtD
Ofloxacin—ABCC1—Disease—GPC3—kidney cancer	3.9e-05	0.00135	CbGpPWpGaD
Ofloxacin—Erythema multiforme—Doxorubicin—kidney cancer	3.9e-05	0.00013	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.89e-05	0.00135	CbGpPWpGaD
Ofloxacin—Pain—Capecitabine—kidney cancer	3.88e-05	0.000129	CcSEcCtD
Ofloxacin—Constipation—Capecitabine—kidney cancer	3.88e-05	0.000129	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—GSTT1—kidney cancer	3.85e-05	0.00134	CbGpPWpGaD
Ofloxacin—Eye disorder—Doxorubicin—kidney cancer	3.85e-05	0.000128	CcSEcCtD
Ofloxacin—Tinnitus—Doxorubicin—kidney cancer	3.84e-05	0.000128	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—kidney cancer	3.82e-05	0.000127	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—kidney cancer	3.82e-05	0.000127	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.81e-05	0.00132	CbGpPWpGaD
Ofloxacin—Diarrhoea—Paclitaxel—kidney cancer	3.79e-05	0.000126	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—kidney cancer	3.78e-05	0.00131	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	3.76e-05	0.00131	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	3.76e-05	0.00131	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Capecitabine—kidney cancer	3.74e-05	0.000124	CcSEcCtD
Ofloxacin—Angiopathy—Doxorubicin—kidney cancer	3.74e-05	0.000124	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—GLIPR1—kidney cancer	3.73e-05	0.0013	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPAT—kidney cancer	3.73e-05	0.0013	CbGpPWpGaD
Ofloxacin—Immune system disorder—Doxorubicin—kidney cancer	3.72e-05	0.000124	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	3.72e-05	0.00129	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Capecitabine—kidney cancer	3.71e-05	0.000124	CcSEcCtD
Ofloxacin—Mediastinal disorder—Doxorubicin—kidney cancer	3.71e-05	0.000124	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—kidney cancer	3.7e-05	0.000123	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.69e-05	0.00128	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	3.68e-05	0.00128	CbGpPWpGaD
Ofloxacin—Arrhythmia—Doxorubicin—kidney cancer	3.68e-05	0.000122	CcSEcCtD
Ofloxacin—Dizziness—Paclitaxel—kidney cancer	3.66e-05	0.000122	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.65e-05	0.00127	CbGpPWpGaD
Ofloxacin—Alopecia—Doxorubicin—kidney cancer	3.64e-05	0.000121	CcSEcCtD
Ofloxacin—Mental disorder—Doxorubicin—kidney cancer	3.61e-05	0.00012	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—PTGS1—kidney cancer	3.61e-05	0.00125	CbGpPWpGaD
Ofloxacin—Urticaria—Capecitabine—kidney cancer	3.61e-05	0.00012	CcSEcCtD
Ofloxacin—ABCC1—Disease—ST3GAL2—kidney cancer	3.61e-05	0.00125	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.61e-05	0.00125	CbGpPWpGaD
Ofloxacin—Abdominal pain—Capecitabine—kidney cancer	3.59e-05	0.000119	CcSEcCtD
Ofloxacin—Body temperature increased—Capecitabine—kidney cancer	3.59e-05	0.000119	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—kidney cancer	3.59e-05	0.000119	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—kidney cancer	3.59e-05	0.000119	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	3.58e-05	0.00124	CbGpPWpGaD
Ofloxacin—Flatulence—Doxorubicin—kidney cancer	3.54e-05	0.000118	CcSEcCtD
Ofloxacin—Tension—Doxorubicin—kidney cancer	3.52e-05	0.000117	CcSEcCtD
Ofloxacin—Vomiting—Paclitaxel—kidney cancer	3.52e-05	0.000117	CcSEcCtD
Ofloxacin—Dysgeusia—Doxorubicin—kidney cancer	3.51e-05	0.000117	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.51e-05	0.00122	CbGpPWpGaD
Ofloxacin—Rash—Paclitaxel—kidney cancer	3.49e-05	0.000116	CcSEcCtD
Ofloxacin—Dermatitis—Paclitaxel—kidney cancer	3.49e-05	0.000116	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—kidney cancer	3.48e-05	0.000116	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—FH—kidney cancer	3.47e-05	0.0012	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APRT—kidney cancer	3.47e-05	0.0012	CbGpPWpGaD
Ofloxacin—Back pain—Doxorubicin—kidney cancer	3.47e-05	0.000115	CcSEcCtD
Ofloxacin—Headache—Paclitaxel—kidney cancer	3.47e-05	0.000115	CcSEcCtD
Ofloxacin—Muscle spasms—Doxorubicin—kidney cancer	3.45e-05	0.000115	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.43e-05	0.00119	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.39e-05	0.00118	CbGpPWpGaD
Ofloxacin—Vision blurred—Doxorubicin—kidney cancer	3.38e-05	0.000112	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—BIRC5—kidney cancer	3.38e-05	0.00117	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PGK1—kidney cancer	3.38e-05	0.00117	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC5A3—kidney cancer	3.38e-05	0.00117	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.36e-05	0.00117	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Capecitabine—kidney cancer	3.35e-05	0.000111	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.33e-05	0.00116	CbGpPWpGaD
Ofloxacin—Ill-defined disorder—Doxorubicin—kidney cancer	3.33e-05	0.000111	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—kidney cancer	3.32e-05	0.00011	CcSEcCtD
Ofloxacin—ABCC1—Disease—LDHB—kidney cancer	3.31e-05	0.00115	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SFRP2—kidney cancer	3.31e-05	0.00115	CbGpPWpGaD
Ofloxacin—Agitation—Doxorubicin—kidney cancer	3.3e-05	0.00011	CcSEcCtD
Ofloxacin—Nausea—Paclitaxel—kidney cancer	3.29e-05	0.000109	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.26e-05	0.00113	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GPC3—kidney cancer	3.26e-05	0.00113	CbGpPWpGaD
Ofloxacin—Asthenia—Capecitabine—kidney cancer	3.26e-05	0.000108	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.24e-05	0.00112	CbGpPWpGaD
Ofloxacin—Malaise—Doxorubicin—kidney cancer	3.24e-05	0.000108	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.22e-05	0.00112	CbGpPWpGaD
Ofloxacin—Vertigo—Doxorubicin—kidney cancer	3.22e-05	0.000107	CcSEcCtD
Ofloxacin—Syncope—Doxorubicin—kidney cancer	3.22e-05	0.000107	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.21e-05	0.00112	CbGpPWpGaD
Ofloxacin—Pruritus—Capecitabine—kidney cancer	3.21e-05	0.000107	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—kidney cancer	3.21e-05	0.000107	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.19e-05	0.00111	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	3.18e-05	0.00111	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CA2—kidney cancer	3.18e-05	0.0011	CbGpPWpGaD
Ofloxacin—Palpitations—Doxorubicin—kidney cancer	3.17e-05	0.000105	CcSEcCtD
Ofloxacin—Loss of consciousness—Doxorubicin—kidney cancer	3.15e-05	0.000105	CcSEcCtD
Ofloxacin—Cough—Doxorubicin—kidney cancer	3.13e-05	0.000104	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	3.13e-05	0.00109	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.11e-05	0.00108	CbGpPWpGaD
Ofloxacin—Diarrhoea—Capecitabine—kidney cancer	3.11e-05	0.000103	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—kidney cancer	3.1e-05	0.000103	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ALAD—kidney cancer	3.09e-05	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TCEB1—kidney cancer	3.09e-05	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TCEB2—kidney cancer	3.09e-05	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.08e-05	0.00107	CbGpPWpGaD
Ofloxacin—Arthralgia—Doxorubicin—kidney cancer	3.05e-05	0.000102	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—kidney cancer	3.05e-05	0.000102	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—kidney cancer	3.05e-05	0.000102	CcSEcCtD
Ofloxacin—Anxiety—Doxorubicin—kidney cancer	3.04e-05	0.000101	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.03e-05	0.000101	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ST3GAL2—kidney cancer	3.02e-05	0.00105	CbGpPWpGaD
Ofloxacin—Discomfort—Doxorubicin—kidney cancer	3.02e-05	0.0001	CcSEcCtD
Ofloxacin—Dizziness—Capecitabine—kidney cancer	3e-05	9.99e-05	CcSEcCtD
Ofloxacin—Dry mouth—Doxorubicin—kidney cancer	2.99e-05	9.93e-05	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.98e-05	0.00103	CbGpPWpGaD
Ofloxacin—Confusional state—Doxorubicin—kidney cancer	2.95e-05	9.82e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ALDH1A1—kidney cancer	2.95e-05	0.00102	CbGpPWpGaD
Ofloxacin—Oedema—Doxorubicin—kidney cancer	2.93e-05	9.74e-05	CcSEcCtD
Ofloxacin—Anaphylactic shock—Doxorubicin—kidney cancer	2.93e-05	9.74e-05	CcSEcCtD
Ofloxacin—Infection—Doxorubicin—kidney cancer	2.91e-05	9.67e-05	CcSEcCtD
Ofloxacin—Vomiting—Capecitabine—kidney cancer	2.89e-05	9.6e-05	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—kidney cancer	2.88e-05	9.58e-05	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.88e-05	0.001	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	2.88e-05	0.000999	CbGpPWpGaD
Ofloxacin—Nervous system disorder—Doxorubicin—kidney cancer	2.87e-05	9.55e-05	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—kidney cancer	2.87e-05	9.53e-05	CcSEcCtD
Ofloxacin—Rash—Capecitabine—kidney cancer	2.86e-05	9.52e-05	CcSEcCtD
Ofloxacin—Dermatitis—Capecitabine—kidney cancer	2.86e-05	9.52e-05	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—kidney cancer	2.86e-05	9.5e-05	CcSEcCtD
Ofloxacin—Headache—Capecitabine—kidney cancer	2.85e-05	9.46e-05	CcSEcCtD
Ofloxacin—Skin disorder—Doxorubicin—kidney cancer	2.84e-05	9.46e-05	CcSEcCtD
Ofloxacin—Hyperhidrosis—Doxorubicin—kidney cancer	2.83e-05	9.41e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—SLC5A3—kidney cancer	2.83e-05	0.000982	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PGK1—kidney cancer	2.83e-05	0.000982	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	2.82e-05	0.000978	CbGpPWpGaD
Ofloxacin—Anorexia—Doxorubicin—kidney cancer	2.79e-05	9.28e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—LDHB—kidney cancer	2.78e-05	0.000963	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—kidney cancer	2.76e-05	0.00096	CbGpPWpGaD
Ofloxacin—Hypotension—Doxorubicin—kidney cancer	2.74e-05	9.1e-05	CcSEcCtD
Ofloxacin—Nausea—Capecitabine—kidney cancer	2.7e-05	8.97e-05	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—GSTP1—kidney cancer	2.67e-05	0.000927	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.67e-05	8.87e-05	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	2.66e-05	0.000923	CbGpPWpGaD
Ofloxacin—Insomnia—Doxorubicin—kidney cancer	2.65e-05	8.81e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	2.63e-05	0.000914	CbGpPWpGaD
Ofloxacin—Paraesthesia—Doxorubicin—kidney cancer	2.63e-05	8.74e-05	CcSEcCtD
Ofloxacin—Dyspnoea—Doxorubicin—kidney cancer	2.61e-05	8.68e-05	CcSEcCtD
Ofloxacin—Somnolence—Doxorubicin—kidney cancer	2.6e-05	8.66e-05	CcSEcCtD
Ofloxacin—Dyspepsia—Doxorubicin—kidney cancer	2.58e-05	8.57e-05	CcSEcCtD
Ofloxacin—Decreased appetite—Doxorubicin—kidney cancer	2.55e-05	8.46e-05	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.54e-05	0.000881	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—RAF1—kidney cancer	2.53e-05	0.000878	CbGpPWpGaD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.53e-05	8.41e-05	CcSEcCtD
Ofloxacin—Fatigue—Doxorubicin—kidney cancer	2.52e-05	8.39e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—RPL14—kidney cancer	2.51e-05	0.000872	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	2.51e-05	0.00087	CbGpPWpGaD
Ofloxacin—Pain—Doxorubicin—kidney cancer	2.5e-05	8.33e-05	CcSEcCtD
Ofloxacin—Constipation—Doxorubicin—kidney cancer	2.5e-05	8.33e-05	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.46e-05	0.000853	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2.45e-05	0.000852	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.43e-05	0.000843	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	2.42e-05	0.00084	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Doxorubicin—kidney cancer	2.41e-05	8.02e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CA9—kidney cancer	2.41e-05	0.000835	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Doxorubicin—kidney cancer	2.39e-05	7.96e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.35e-05	0.000816	CbGpPWpGaD
Ofloxacin—Urticaria—Doxorubicin—kidney cancer	2.33e-05	7.74e-05	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.33e-05	0.000807	CbGpPWpGaD
Ofloxacin—Body temperature increased—Doxorubicin—kidney cancer	2.31e-05	7.7e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—kidney cancer	2.31e-05	7.7e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.29e-05	0.000796	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ITPR2—kidney cancer	2.27e-05	0.000788	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2A—kidney cancer	2.24e-05	0.000777	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	2.22e-05	0.00077	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Doxorubicin—kidney cancer	2.16e-05	7.17e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	2.12e-05	0.000735	CbGpPWpGaD
Ofloxacin—Asthenia—Doxorubicin—kidney cancer	2.1e-05	6.99e-05	CcSEcCtD
Ofloxacin—Pruritus—Doxorubicin—kidney cancer	2.07e-05	6.89e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CRABP1—kidney cancer	2.05e-05	0.00071	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ACY1—kidney cancer	2.05e-05	0.00071	CbGpPWpGaD
Ofloxacin—Diarrhoea—Doxorubicin—kidney cancer	2e-05	6.66e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—CDKN1B—kidney cancer	1.98e-05	0.000689	CbGpPWpGaD
Ofloxacin—Dizziness—Doxorubicin—kidney cancer	1.94e-05	6.44e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—PSMD7—kidney cancer	1.9e-05	0.000661	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—kidney cancer	1.9e-05	0.00066	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ITPR2—kidney cancer	1.9e-05	0.00066	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND1—kidney cancer	1.89e-05	0.000657	CbGpPWpGaD
Ofloxacin—Vomiting—Doxorubicin—kidney cancer	1.86e-05	6.19e-05	CcSEcCtD
Ofloxacin—Rash—Doxorubicin—kidney cancer	1.85e-05	6.14e-05	CcSEcCtD
Ofloxacin—Dermatitis—Doxorubicin—kidney cancer	1.84e-05	6.13e-05	CcSEcCtD
Ofloxacin—Headache—Doxorubicin—kidney cancer	1.83e-05	6.1e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.75e-05	0.000609	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	1.75e-05	0.000606	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.74e-05	0.000606	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PDHB—kidney cancer	1.74e-05	0.000604	CbGpPWpGaD
Ofloxacin—Nausea—Doxorubicin—kidney cancer	1.74e-05	5.78e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—GSTT1—kidney cancer	1.73e-05	0.000602	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ACHE—kidney cancer	1.73e-05	0.000602	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—POMC—kidney cancer	1.73e-05	0.000602	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC2A1—kidney cancer	1.72e-05	0.000597	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—JUNB—kidney cancer	1.71e-05	0.000593	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	1.7e-05	0.000589	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	1.66e-05	0.000576	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SCARB1—kidney cancer	1.64e-05	0.00057	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CCBL1—kidney cancer	1.64e-05	0.000568	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS1—kidney cancer	1.63e-05	0.000564	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PSMD7—kidney cancer	1.59e-05	0.000553	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAPK3—kidney cancer	1.56e-05	0.000542	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MYC—kidney cancer	1.52e-05	0.000527	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—BCHE—kidney cancer	1.51e-05	0.000524	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC5A5—kidney cancer	1.49e-05	0.000518	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAPK1—kidney cancer	1.49e-05	0.000515	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.48e-05	0.000513	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC2A1—kidney cancer	1.44e-05	0.0005	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.44e-05	0.000498	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPAT—kidney cancer	1.42e-05	0.000492	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.42e-05	0.000492	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.4e-05	0.000486	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.4e-05	0.000485	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.39e-05	0.000483	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN2B—kidney cancer	1.39e-05	0.000483	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.39e-05	0.000481	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.37e-05	0.000477	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—FH—kidney cancer	1.32e-05	0.000458	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APRT—kidney cancer	1.32e-05	0.000458	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.29e-05	0.000447	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—kidney cancer	1.25e-05	0.000433	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GPC3—kidney cancer	1.24e-05	0.00043	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.22e-05	0.000423	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CA2—kidney cancer	1.21e-05	0.000419	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTP1—kidney cancer	1.2e-05	0.000417	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALAD—kidney cancer	1.18e-05	0.000408	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.15e-05	0.000398	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCB1—kidney cancer	1.14e-05	0.000395	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.12e-05	0.000389	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HIF1A—kidney cancer	1.11e-05	0.000386	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TSC2—kidney cancer	1.11e-05	0.000385	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTM1—kidney cancer	1.1e-05	0.000383	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PGK1—kidney cancer	1.07e-05	0.000373	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.07e-05	0.000373	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LDHB—kidney cancer	1.05e-05	0.000366	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP1A1—kidney cancer	1.05e-05	0.000364	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KIT—kidney cancer	9.8e-06	0.00034	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APC—kidney cancer	9.8e-06	0.00034	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BRAF—kidney cancer	9.21e-06	0.00032	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CA9—kidney cancer	9.14e-06	0.000317	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.93e-06	0.00031	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.6e-06	0.000299	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—POMC—kidney cancer	7.81e-06	0.000271	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CRABP1—kidney cancer	7.77e-06	0.00027	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RAF1—kidney cancer	7.69e-06	0.000267	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ERBB2—kidney cancer	7.61e-06	0.000264	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTOR—kidney cancer	7.51e-06	0.000261	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD4—kidney cancer	7.49e-06	0.00026	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—kidney cancer	7.44e-06	0.000258	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ITPR2—kidney cancer	7.22e-06	0.000251	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN1B—kidney cancer	7.04e-06	0.000244	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.66e-06	0.000231	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CTNNB1—kidney cancer	6.65e-06	0.000231	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTT1—kidney cancer	6.59e-06	0.000229	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ACHE—kidney cancer	6.59e-06	0.000229	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTEN—kidney cancer	6.49e-06	0.000225	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SCARB1—kidney cancer	6.24e-06	0.000216	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—kidney cancer	6.23e-06	0.000216	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS1—kidney cancer	6.17e-06	0.000214	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PSMD7—kidney cancer	6.05e-06	0.00021	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BCHE—kidney cancer	5.74e-06	0.000199	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.67e-06	0.000197	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK3—kidney cancer	5.54e-06	0.000192	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.47e-06	0.00019	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTEN—kidney cancer	5.43e-06	0.000189	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MYC—kidney cancer	5.39e-06	0.000187	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.31e-06	0.000184	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK1—kidney cancer	5.27e-06	0.000183	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KRAS—kidney cancer	4.98e-06	0.000173	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.63e-06	0.000161	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CA—kidney cancer	4.58e-06	0.000159	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTP1—kidney cancer	4.57e-06	0.000158	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCB1—kidney cancer	4.32e-06	0.00015	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTM1—kidney cancer	4.2e-06	0.000146	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.98e-06	0.000138	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CA—kidney cancer	3.83e-06	0.000133	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.27e-06	0.000113	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—POMC—kidney cancer	2.97e-06	0.000103	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—kidney cancer	2.37e-06	8.21e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTEN—kidney cancer	2.06e-06	7.16e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.46e-06	5.05e-05	CbGpPWpGaD
